Related Experiment Video
Updated: Jun 25, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
The Fontan Adult Brompton clinical score and mortality risk
Claudia Montanaro1,2, Alexandra Arvanitaki1,3, William Kerrigan1
1Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, Guy's and St Thomas's NHS Foundation Trust, London SW3 5NP, United Kingdom.
Adults with Fontan palliation face higher mortality risks. A new clinical score using readily available data helps identify those at risk for death or heart transplantation, enabling personalized care.
Area of Science:
- Cardiology
- Congenital Heart Disease
- Adult Congenital Heart Disease
Background:
- Adults with Fontan palliation have an elevated risk of premature death.
- Personalized care is crucial for this growing population with complex congenital heart disease.
Purpose of the Study:
- To develop a risk score for predicting mortality or heart transplantation in adults with Fontan circulation.
- To utilize widely available clinical variables for risk stratification at the first adult visit.
Main Methods:
- Retrospective study of adults with Fontan circulation at their first adult congenital heart disease visit.
- Multivariate prognostic model developed using stepwise backward conditional approach.
- External validation of the derived risk score in a separate cohort.
Main Results:
- A risk score was derived using age, atrial tachyarrhythmia history, heart failure, NYHA class, systolic blood pressure, and oxygen saturation.
- The score effectively discriminated patients into low, intermediate, and high risk groups (C-index: 0.71).
- External validation demonstrated excellent discriminative ability (C-index: 0.92).
Conclusions:
- A novel, externally validated clinical score identifies adults with Fontan palliation at risk of mortality or transplantation.
- This score facilitates personalized care for adults with complex congenital heart disease.
- The risk score is based on readily available clinical variables.
More Related Videos
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Related Concept Videos
Pre-Procedural Guidelines for Assessing Blood Pressure
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pulmonary Embolism I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Hazard Ratio
For example, in a clinical trial evaluating a...